Advertisement

Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common

Published:November 06, 2019DOI:https://doi.org/10.1016/j.amjmed.2019.10.005

      Abstract

      Chikungunya virus (CHIKV) is a single-stranded RNA virus belonging to the family Togaviridae and genus Alphavirus that causes an acute febrile illness, chikungunya fever, which is transmitted to humans by Aedes species mosquitoes. During acute illness, patients have high fever, polyarthralgias or polyarthritis, maculopapular rash, headache, and myalgia that lasts for days to weeks. Following resolution of acute infection, a significant proportion of patients develop chronic chikungunya arthritis that can resemble rheumatoid arthritis. In this review, we first consider the historical background of infectious causes of inflammatory arthritis, and then the pathogenic and clinical manifestations of chronic chikungunya arthritis as a rheumatoid arthritis mimic. We believe that chronic chikungunya arthritis may be a postinfectious inflammatory process, and that an understanding of the parallels and differences between chronic chikungunya arthritis and rheumatoid arthritis may offer insights into better diagnosis and treatment of both diseases.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wimalasiri-Yapa BM
        • Stassen L
        • Huang X
        • et al.
        Chikungunya virus in Asia-Pacific: a systematic review.
        Emerg Microbes Infect. 2019; 8: 70-79https://doi.org/10.1080/22221751.2018.1559708
        • LaBeaud A
        • Bashir F
        • King CH
        Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections.
        Popul Health Metr. 2011; 9https://doi.org/10.1186/1478-7954-9-1
        • Paul BJ
        • Sadanand S
        Chikungunya infection: a re-emerging epidemic.
        Rheumatol Ther. 2018; 5: 317-326https://doi.org/10.1007/s40744-018-0121-7
        • Weaver SC
        • Lecuit M
        Chikungunya virus and the global spread of a mosquito-borne disease.
        N Engl J Med. 2015; 372: 1231-1239
        • Thiberville S
        • Moyen N
        • Dupuis-Maguiraga L
        • et al.
        Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy.
        Antiviral Research. 2013; 99: 345-370https://doi.org/10.1016/j.antiviral.2013.06.009
        • Rodríguez-Morales AJ
        • Cardona-Ospina JA
        • Fernanda Urbano-Garzón S
        • Sebastian Hurtado-Zapata J
        Prevalence of post-Chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis.
        Arthritis Care Res. 2016; 68: 1849-1858https://doi.org/10.1002/acr.22900
        • Javelle E
        • Ribera A
        • Degasne I
        • Gaüzère B
        • Marimoutou C
        • Simon F
        Specific management of post-Chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.
        PLOS Negl Tro Dis. 2015; 9e0003603https://doi.org/10.1371/journal.pntd.0003603
        • Bouquillard É
        • Combe B
        A report of 21 cases of rheumatoid arthritis following Chikungunya fever: a mean follow-up of two years.
        Joint Bone Spine. 2009; 76: 654-657https://doi.org/10.1016/j.jbspin.2009.08.005
        • Amaral JK
        • Bingham CO
        • Schoen RT
        Successful methotrexate treatment of chronic Chikungunya arthritis.
        JCR: J Clini Rheumatol. 2018; 1https://doi.org/10.1097/00124743-900000000-99120
        • Amaral JK
        • Taylor PC
        • Teixeira MM
        • Morrison TE
        • Schoen RT
        The clinical features, pathogenesis and methotrexate therapy of chronic Chikungunya arthritis.
        Viruses. 2019; 11: 289
        • Zaid A
        • Gérardin P
        • Taylor A
        • Mostafavi H
        • Malvy D
        • Mahalingam S
        Review: Chikungunya arthritis: implications of acute and chronic inflammation mechanisms on disease management.
        Arthritis Rheumatol. 2018; 70: 484-495https://doi.org/10.1002/art.40403
        • Chaaithanya IK
        • Muruganandam N
        • Sundaram SG
        • et al.
        Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection.
        Viral Immunol. 2011; 24: 265-271https://doi.org/10.1089/vim.2010.0123
        • Hoarau JJ
        • Jaffar Bandjee MC
        • Krejbich Trotot P
        • et al.
        Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response.
        J. Immunol. 2010; 184: 5914-5927
        • Chow A
        • Her Z
        • Ong EK
        • et al.
        Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
        J Infect Dis. 2011; 203: 149-157
        • Tiwari V
        • Bergman MJ
        Viral arthritis.
        ([Updated 2019 Jun 4])StatPearls. StatPearls Publishing, Treasure Island (FL)2019 (Jan. Available from:)
        • Perl A
        Mechanisms of viral pathogenesis in rheumatic disease.
        Ann Rheum Dis. 1999; 58: 454-461https://doi.org/10.1136/ard.58.8.454
        • Marks M
        • Marks JL
        Viral arthritis.
        Clin Med. 2016; 16: 129-134https://doi.org/10.7861/clinmedicine.16-2-129
        • Vassilopoulos D
        • Calabres LH
        Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations.
        Arthritis Res Ther. 2008; 10: 215https://doi.org/10.1186/ar2480
        • Albert LJ
        • Inman RD
        Molecular mimicry and autoimmunity.
        N Engl J Med. 1999; 341: 2068-2074https://doi.org/10.1056/nejm199912303412707
        • Tsokos G
        Overview of cellular immune function in systemic lupus erythematosus.
        Systemic Lupus Erythematosus. 2004; : 29-92https://doi.org/10.1016/b9-78-012433-9/01950-0053
        • Clerici M
        • Shearer GM
        The Th1–Th2 hypothesis of HIV infection: new insights.
        Immunol Today. 1994; 15: 575-581https://doi.org/10.1016/0167-5699(94)90220-8
        • Naides SJ
        Rheumatic manifestations of parvovirus b19 infection.
        Rheum Dis Clin North Am. 1998; 24: 375-401https://doi.org/10.1016/s0889-857x(05)70014-4
        • Sayiner ZA
        • Haque U
        • Malik MU
        • Gurakar A
        Hepatitis C virus infection and its rheumatologic implications.
        Gastroenterol Hepatol. 2014; 10: 287-293
        • Nishioka KJ
        HTLV-I Arthropathy and Sjögren Syndrome.
        J Acqui Immune Defic Syndr Hu Retrovirol. 1996; 13: S57-S62https://doi.org/10.1097/00042560-199600001-00011
        • Draborg AH
        • Duus K
        • Houen G
        Epstein-Barr virus in systemic autoimmune diseases.
        Clin Develop Immunol. 2013; 2013: 1-9https://doi.org/10.1155/2013/535738
        • Kalden JR
        • Gay S
        Retroviruses and autoimmune rheumatic diseases.
        Clin Exp Immunol. 2008; 98: 1-5https://doi.org/10.1111/j.1365-2249.1994.tb06597.x
        • McInnes IB
        • Schett G
        The pathogenesis of rheumatoid arthritis.
        N Engl J Med. 2011; 365: 2205-2219https://doi.org/10.1056/nejmra1004965
        • Scott DL
        • Wolfe F
        • Huizinga TW
        Rheumatoid arthritis.
        The Lancet. 2010; 376: 1094-1108https://doi.org/10.1016/s0140-6736(10)60826-4
        • Bach JF
        Infections and autoimmune diseases.
        J Autoimmun. 2005; 25: 74-80https://doi.org/10.1016/j.jaut.2005.09.024
        • Arleevskaya MI
        • Kravtsova OA
        • Lemerle J
        • Renaudineau Y
        • Tsibulkin AP
        How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses.
        Front Microbiol. 2016; 7: 1296https://doi.org/10.3389/fmicb.2016.01296
        • Griffiths SJ
        • Riddell NE
        • Masters J
        • et al.
        Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA.
        J Immunol. 2013; 190: 5363-5372https://doi.org/10.4049/jimmunol.1203267
        • Halenius A
        • Hengel H
        Human cytomegalovirus and autoimmune disease.
        BioMed Res Int. 2014; 2014: 1-15https://doi.org/10.1155/2014/472978
        • Taneja V
        Cytokines pre-determined by genetic factors are involved in pathogenesis of rheumatoid arthritis.
        Cytokine. 2015; 75: 216-221https://doi.org/10.1016/j.cyto.2014.11.028
        • Saal JG
        • Krimmel M
        • Steidle M
        • et al.
        Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.
        Arthritis Rheum. 1999; 42: 1485-1496https://doi.org/10.1002/1529-0131(199907)42:7<1485::aid-anr24>3.0.co;2-7
        • Fleming A
        • Dodman S
        • Crown JM
        • Corbett M
        Extra-articular features in early rheumatoid disease.
        BMJ. 1976; 1: 1241-1243https://doi.org/10.1136/bmj.1.6020.1241
        • Fleming A
        • Benn RT
        • Corbett M
        • Wood PH
        Early rheumatoid disease. II. Patterns of joint involvement.
        Ann Rheum Dis. 1976; 35: 361-364https://doi.org/10.1136/ard.35.4.361
        • Van Aken J
        Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study.
        Ann Rheum Dis. 2006; 65: 20-25https://doi.org/10.1136/ard.2005.038471
        • Firestein GS
        • Budd R
        • Gabriel SE
        • McInnes IB
        • O'Dell JR
        Clinical features of rheumatoid arthritis.
        Kelley's Textbook of Rheumatology E-Book. 9th ed. Elsevier Health Sciences, St. Louis, MO2012: 1109-1135 (p. 1111)
        • Borgherini G
        • Poubeau P
        • Jossaume A
        • et al.
        Persistent Arthralgia Associated with Chikungunya Virus: A Study of 88 Adult Patients on Reunion Island.
        Clin Infect Dis. 2008; 47: 469-475https://doi.org/10.1086/590003
        • Rodriguez-Morales AJ
        • Gil-Restrepo AF
        • Ramírez-Jaramillo V
        • et al.
        Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia.
        F1000Research. 2016; 5: 360https://doi.org/10.12688/f1000research.8235.2
        • Schilte C
        • Staikovsky F
        • Couderc T
        • et al.
        Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study.
        PLoS Negl Trop Dis. 2013; 7: e2137https://doi.org/10.1371/journal.pntd.0002137
        • Manimunda SP
        • Vijayachari P
        • Uppoor R
        • et al.
        Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging.
        Trans R Soc Trop Med Hyg. 2010; 104: 392-399https://doi.org/10.1016/j.trstmh.2010.01.011
        • Chaaitanya IK
        • Muruganandam N
        • Sundaram SG
        • et al.
        Role of pro-inflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection.
        Viral Immunol. 2011; 24: 265-271
        • Chow A
        • Her Z
        • Ong EK
        • et al.
        Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
        J Infect Dis. 2011; 203: 149-157https://doi.org/10.1093/infdis/jiq042
        • Dupuis-Maguiraga L
        • Noret M
        • Brun S
        • Le Grand R
        • Gras G
        • Roques P
        Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.
        PLoS Negl Trop Dis. 2012; 6: e1446https://doi.org/10.1371/journal.pntd.0001446
        • Ng LF
        • Chow A
        • Sun Y
        • et al.
        IL-1b, IL-6, and RANTES as biomarkers of chikungunya severity.
        PLoS One. 2009; 4: e4261
        • Jaller Raad J
        • Segura Rosero A
        • Vidal Martínez J
        • et al.
        Respuesta inmunitaria de una población del Caribe colombiano infectada con el virus chikungunya.
        Revista Colombiana de Reumatología. 2016; 23: 85-91
        • Chang AY
        • Martins KAO
        • Encinales L
        • et al.
        A cross-sectional analysis of chikungunya arthritis patients 22-months post-infection demonstrate no detectable viral persistence in synovial fluid.
        Arthritis Rheumatol. 2017; 70: 585-593https://doi.org/10.1002/art.40383
        • Miossec P
        • Korn T
        • Kuchroo VK
        Interleukin-17 and type 17 helper T cells.
        N Engl J Med. 2009; 361: 888-898
        • Noret M
        Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts.
        J Infect Dis. 2012; 206: 455-457
        • Hochberg MC
        Systemic lupus erythematosus.
        Rheum Dis Clin North Am. 1990; 16: 617-639
        • Thanapati S
        • Ganu MA
        • Tripathy AS
        Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya.
        PLoS One. 2017; 12e0188342https://doi.org/10.1371/journal.pone.0188342
        • Amaral JK
        • Sutaria R
        • Schoen RT
        Treatment of chronic chikungunya arthritis with methotrexate: a systematic review.
        Arthritis Care Res. 2018; 70: 1501-1508https://doi.org/10.1002/acr.23519
        • Blettery M
        • Brunier L
        • Polomat K
        • et al.
        Brief report: management of chronic post-Chikungunya rheumatic disease: the Martinican experience.
        Arthritis Rheumatol. 2016; 68: 2817-2824https://doi.org/10.1002/art.39775
        • Cutolo M
        Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
        Ann Rheum Dis. 2001; 60: 729-735
        • Wessels JA
        • Huizinga TW
        • Guchelaar H
        Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.
        Rheumatology (Oxford). 2007; 47: 249-255
        • Tian H
        • Cronstein B
        Understanding the mechanisms of action of methotrexate: Implications for the treatment of rheumatoid arthritis.
        Bull NYU Hosp Jt Dis. 2007; 65: 168-173
        • Amaral JK
        • Bilsborrow JB
        • Schoen RT
        Brief report: the disability of chronic chikungunya arthritis.
        Clin Rheumatol. 2019; 38: 2011-2014https://doi.org/10.1007/s10067-019-04529-x
        • Bedoui Y
        • Giry C
        • Jaffar-Bandjee M
        • Selambarom J
        • Guiraud P
        • Gasque P
        Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses.
        PLOS Negl Trop Dis. 2018; 12e0006634https://doi.org/10.1371/journal.pntd.0006634